$IRON News and Market Events
Every $IRON story Market Flux has tracked.
- Unusual Volume
Disc Medicine Surges 60% After Bitopertin Hits All Phase 3 APOLLO Endpoints in Rare Sun-Sensitivity Disease
Disc Medicine shares rocketed as much as 60% on October 19 after the company announced that its investigational drug bitopertin met all primary and secondary endpoints in the pivotal Phase…
- Top Story
Disc Medicine Surges 60% on Phase 3 Win for Rare Sunlight Disorder Drug Developed With Roche
Disc Medicine's shares rocketed as much as 60 percent after the company reported positive Phase 3 results for its lead asset developed in collaboration with Roche, targeting erythropoietic…
- Market Flux Event
Disc Medicine Surges 60% After Phase 3 APOLLO Trial of Bitopertin Meets All Endpoints in Rare Sun-Sensitivity Disease
Disc Medicine, trading on Nasdaq under the ticker IRON, surged roughly 60% on October 19 after reporting that its pivotal Phase 3 APOLLO trial of bitopertin met all primary and secondary…
- Market Flux Event
Disc Medicine Surges 60% on Phase 3 Win for Rare Sunlight Disorder Drug Developed With Roche
Disc Medicine's shares rocketed as much as 60 percent after the company reported positive Phase 3 results for its lead asset developed in collaboration with Roche, targeting erythropoietic…